Sio Gene Therapies Inc.

NASDAQ:SIOX

0.41 (USD) • At close September 17, 2024
Bedrijfsnaam Sio Gene Therapies Inc.
Symbool SIOX
Munteenheid USD
Prijs 0.478
Beurswaarde 0
Dividendpercentage 91%
52-weken bereik 0.25 - 0.5
Industrie Biotechnology
Sector Healthcare
CEO Mr. David W. Nassif J.D.
Website https://www.siogtx.com

An error occurred while fetching data.

Over Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to

Vergelijkbare Aandelen

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

LABP

22.93 USD

Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.

ONTX

0.995 USD

Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

ABEO

5.49 USD

Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.

AYTU

1.213 USD

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

0.252 USD

Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.

EKSO

0.413 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)